Tremollieres F
MCU-PH en médecine et biologie du développement et de la reproduction, centre de ménopause, hôpital Paule-de-Viguier, Toulouse, France.
Gynecol Obstet Fertil. 2010 Jun;38(6):388-93. doi: 10.1016/j.gyobfe.2010.04.005. Epub 2010 Jun 4.
The pathophysiology of pelvic floor disorders still remains not well understood. Increasing age as well as vaginal multiparity are the main commonly accepted factors. The hypothesis of a defect of connective tissues of the pelvic floor with aging due to collagen deficiency and/or elastic fiber degradation is often highlighted. The issue of a potential protective role of HRT is also discussed although the recent results from the WHI would suggest a negative impact of HRT on urinary incontinence, especially when HRT is initiated in elderly women, far from the menopause. Nevertheless, environmental factors cannot explain the full pathogenesis of pelvic organ prolapse (POP) and the contribution of genetic factors to the development of pelvic floor disorders is widely recognized. Support for a genetic influence on POP derives from reports suggesting that heritability is a strong contributing factor and a familial history of POP is considered as a classical risk factor. However, the characterization of the underlying molecular mechanisms remains limited, since POP may be considered the end result of a multifactorial process leading to destruction of vaginal wall connective tissue. Experimental studies in mice with null mutations in the genes encoding different putative factors involved in elastic fibers remodeling and homeostasis are crucial in the understanding of the pathogenesis of POP. Mice with null mutation in the gene encoding lysyl oxidase-like 1 (LOXL1) or fibulin-5, demonstrate signs of elastinopathy including the development of a POP in the postpartum. Likewise, homeobox genes such as HOXA11, which are essential in the embryonic development of the urogenital tract might also be involved in the pathogenesis of POP. The better understanding of the underlying determinants of pelvic floor disorders with a special focus on genetic factors may offer new therapeutic strategies, in addition to or replacement of surgical procedures.
盆底功能障碍的病理生理学仍未得到充分理解。年龄增长以及经阴道分娩多次是主要的公认因素。由于胶原蛋白缺乏和/或弹性纤维降解导致盆底结缔组织随年龄增长出现缺陷的假说常被提及。尽管妇女健康倡议(WHI)最近的结果表明激素替代疗法(HRT)对尿失禁有负面影响,尤其是在老年女性绝经后很久才开始使用HRT时,但HRT潜在保护作用的问题也受到了讨论。然而,环境因素并不能完全解释盆腔器官脱垂(POP)的发病机制,遗传因素对盆底功能障碍发展的影响已得到广泛认可。对POP存在遗传影响的支持来自于一些报告,这些报告表明遗传力是一个重要的促成因素,POP家族史被视为一个典型的风险因素。然而,由于POP可能被认为是导致阴道壁结缔组织破坏的多因素过程的最终结果,其潜在分子机制的特征仍然有限。对编码参与弹性纤维重塑和内稳态的不同假定因子的基因进行无效突变的小鼠实验研究,对于理解POP的发病机制至关重要。编码赖氨酰氧化酶样1(LOXL1)或纤连蛋白-5的基因发生无效突变的小鼠,表现出弹性组织病的迹象,包括产后出现POP。同样,在泌尿生殖道胚胎发育中起关键作用的同源框基因,如HOXA11,也可能参与POP的发病机制。除了手术治疗或作为手术治疗的替代方法外,更深入地了解盆底功能障碍的潜在决定因素,特别是遗传因素,可能会提供新的治疗策略。